Advisors Asset Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$453K Buy
29,904
+18,582
+164% +$466K 0.01% 1106
2026
Q2
$324K Sell
11,322
-4,021
-26% -$128K ﹤0.01% 1070
2026
Q1
$483K Buy
15,343
+327
+2% +$10.3K 0.01% 979
2025
Q4
$442K Buy
15,016
+4,341
+41% +$121K 0.01% 988
2025
Q3
$270K Buy
10,675
+3,065
+40% +$74.7K ﹤0.01% 1081
2025
Q2
$183K Buy
7,610
+4,196
+123% +$97.3K ﹤0.01% 1128
2025
Q1
$78.2K Buy
+3,414
New +$82.4K ﹤0.01% 1240

Other funds holding RTO

Advisors Asset Management's RTO Position: Q3 2026 in Review

Advisors Asset Management increased its Rentokil (RTO) stake by 164% in Q3 2026, buying an estimated $466K and bringing the position to 29,904 shares worth $453K. The position accounts for 0.01% of the portfolio, ranked #1106.

Advisors Asset Management first reported a position in RTO in Q1 2025 and has held it in 7 quarters since. The position peaked at $483K in Q1 2026. 204 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • Advisors Asset Management held 29,904 shares of Rentokil worth $453K as of Q3 2026.
  • Advisors Asset Management bought 18,582 Rentokil shares in Q3 2026, an estimated $466K.
  • Rentokil made up 0.01% of Advisors Asset Management's portfolio in Q3 2026, its #1106 holding.
  • Advisors Asset Management first reported a position in Rentokil in Q1 2025 and has held it in 7 quarters since.
  • Advisors Asset Management's Rentokil position peaked at $483K in Q1 2026.
  • 204 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Advisors Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.